WORCESTER, Mass., May 5, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Generex Oral-lyn(tm), its proprietary oral insulin spray product, has been approved by the Ministry of Health, Populations and Hospitals Reform of Algeria for importation and commercial marketing and sale for the treatment of diabetes in the People’s Democratic Republic of Algeria.
